These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30004159)

  • 1. Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.
    Rampersad AG; Boylan B; Miller CH; Shapiro A
    Haemophilia; 2018 Sep; 24(5):807-814. PubMed ID: 30004159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study.
    Miller CH; Rice AS; Boylan B; Shapiro AD; Lentz SR; Wicklund BM; Kelly FM; Soucie JM;
    J Thromb Haemost; 2013 Jul; 11(7):1300-9. PubMed ID: 23601690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lupus anticoagulants in immediate acting inhibitor positivity in congenital haemophilia A patients.
    Patil R; S C; Parihar A; Mohite A; Shetty S
    Thromb Res; 2018 Dec; 172():29-35. PubMed ID: 30359788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
    Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; ;
    J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.
    Miller CH; Boylan B; Shapiro AD; Lentz SR; Wicklund BM;
    J Thromb Haemost; 2017 Oct; 15(10):1971-1976. PubMed ID: 28795528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of anti-factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents.
    Boylan B; Niemeyer GP; Werner B; Miller CH
    Haemophilia; 2021 Jan; 27(1):e40-e50. PubMed ID: 33216433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
    Blanco AN; Peirano AA; Grosso SH; Gennari LC; Bianco RP; Lazzari MA
    Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.
    Boylan B; Miller CH
    Haemophilia; 2018 May; 24(3):487-491. PubMed ID: 29461004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
    Sahud M; Zhukov O; Mo K; Popov J; Dlott J
    Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.
    Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R
    Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantibodies to factor VIII in haemophilia.
    Zakarija A; Harris S; Rademaker AW; Brewer J; Krudysz-Amblo J; Butenas S; Mann KG; Green D
    Haemophilia; 2011 Jul; 17(4):636-40. PubMed ID: 21299745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
    Oomen I; Verhagen M; Miranda M; Allacher P; Beckers EAM; Blijlevens NMA; van der Bom JG; Coppens M; Driessens M; Eikenboom JCJ; Fijnvandraat K; Hassan S; van Heerde WL; Hooimeijer HL; Jansen JH; Kaijen P; Leebeek FWG; Meijer D; Paul H; Rijpma SR; Rosendaal FR; Smit C; van Vulpen LFD; Voorberg J; Schols SEM; Gouw SC
    Front Immunol; 2024; 15():1355813. PubMed ID: 38455035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for anti-factor VIII antibody levels in haemophilia A patients - validation of a multiplex immunoassay and comparability with assays measuring non-neutralising and neutralising antibodies (inhibitors).
    Martin M; Augustsson C; Lind V; Al-Sabti R; Lam MC; Andersson NG; Strandberg K
    Haemophilia; 2023 Jan; 29(1):336-347. PubMed ID: 36193002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.
    Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Donfield SM; Astermark J; Berntorp E; Lollar P; Schwabe D; Königs C
    Haemophilia; 2017 Mar; 23(2):292-299. PubMed ID: 27862687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay.
    Pezeshkpoor B; Berkemeier AC; Herbst K; Albert T; Müller J; Oldenburg J
    J Thromb Haemost; 2024 Jun; 22(6):1591-1604. PubMed ID: 38453023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
    Kershaw GW; Chen LS; Jayakodi D; Dunkley SM
    Thromb Res; 2013; 132(6):735-41. PubMed ID: 24119613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.